Search results (729)
« Back to PublicationsBiobank-Scale Plasma Proteomics Identifies Novel Biomarkers in Hypertrophic Cardiomyopathy.
Journal article
Chan JH. et al, (2026), Circ Genom Precis Med
Discovery of gene-alcohol interaction loci influencing blood pressure in 1.1 million individuals from multiple populations.
Preprint
Feitosa M. et al, (2026)
Rational discovery of therapeutic PAK1 allosteric activators.
Journal article
He Y. et al, (2026), Cell
Cardiomyopathy Gene Variants and Polygenic Risk Scores in Atrial Fibrillation: Evidence for an Atrial-First Phenotype.
Journal article
da Rocha GL. et al, (2026), J Am Coll Cardiol, 87, 1279 - 1299
Hypertrophic cardiomyopathy caused by filamin-C variants has restrictive and extracardiac features and a distinctive ECG.
Journal article
de Villiers C. et al, (2026), Heart Rhythm
Leveraging the shared and opposing genetic mechanisms in the heritable cardiomyopathies.
Preprint
Kramarenko DR. et al, (2026)
Left Atrial Reservoir Strain Predicts Atrial Fibrillation in Hypertrophic Cardiomyopathy: Insights from the NHLBI HCM Registry.
Journal article
Beyhoff N. et al, (2026), JACC Cardiovasc Imaging, 19, 133 - 135
Myocardial Entropy and Risk Predictors in Hypertrophic Cardiomyopathy: An Analysis From the NHLBI HCM Registry.
Journal article
Antiochos P. et al, (2025), Circ Cardiovasc Imaging, 18
Exploring penetrance of clinically relevant variants in over 800,000 humans from the Genome Aggregation Database.
Journal article
Gudmundsson S. et al, (2025), Nat Commun, 16
Sex Differences in the Genetic Causes of Dilated Cardiomyopathy.
Journal article
Mangino M. et al, (2025), J Am Coll Cardiol, 86, 400 - 403
Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: 48-Week Results From FOREST-HCM.
Journal article
Saberi S. et al, (2025), JACC Heart Fail, 13
Regulatory T cells attenuate chronic inflammation and cardiac fibrosis in hypertrophic cardiomyopathy.
Journal article
Wang Y-J. et al, (2025), Sci Transl Med, 17
Considerations for drug trials in hypertrophic cardiomyopathy.
Journal article
Farrant JP. et al, (2025), ESC Heart Fail, 12, 1095 - 1112
An ALPK3 truncation variant causing autosomal dominant hypertrophic cardiomyopathy is partially rescued by mavacamten.
Journal article
Leinhos L. et al, (2025), Sci Rep, 15
Evaluation of polygenic scores for hypertrophic cardiomyopathy in the general population and across clinical settings.
Journal article
Zheng SL. et al, (2025), Nat Genet, 57, 563 - 571